Metabolically healthy adults who were overweight had a 26% higher risk of heart disease, compared with normal-weight adults, while those who were obese had a 28% higher risk, according to a study in the European Heart Journal. People with three or more heart risk factors had twice the likelihood of developing heart disease regardless of their weight, the study found.
UK researchers found that type 2 diabetes patients with poor medication adherence had a higher risk for cardiovascular disease than those with good medication adherence. The findings in Diabetes Care, based on a meta-analysis of eight observational studies involving 318,125 adult diabetes patients, also revealed an association between good medication adherence and reduced risks for all-cause mortality and hospitalization.
A study in The Lancet Diabetes & Endocrinology showed that adults with type 2 diabetes who were new users of SGLT2 inhibitors had reduced risks for severe hypoglycemia, cardiovascular mortality, all-cause mortality, major CV events and hospital events for heart failure, compared with those who used other glucose-lowering drugs. Researchers analyzed data from CVD-REAL Nordic involving 91,320 patients and found no differences for atrial fibrillation, non-fatal myocardial infarction and stroke between the two groups.
Cleveland Clinic data from 2008 to 2012 showed 16% of myocardial infarction patients were readmitted to the hospital within three months, 39% of which occurred in the first 15 days after discharge, researchers reported in the Journal of the American College of Cardiology. The study found 47% of the readmissions were for MI or other cardiovascular reasons.
Health care organizations want the CMS to do more to ensure hospitals are not unfairly penalized for readmissions due to the socio-demographic makeup of patients. Experts say policy in the 21st Century Cures Act that requires the CMS to consider socio-demographics in readmissions lacks specificity and details, and CMS noted in its final inpatient payment rule that the overall percentage of hospitals being penalized would not show much change.
HHS, with the Trump administration's support, has encouraged states to apply for waivers which would allow them to channel state and federal funding to insurers in order to stabilize their markets by offsetting the cost of care for the most expensive patients. Alaska has already been approved to receive $323 million over the next five years through a provision of the Affordable Care Act that allows states to develop their own health plans as long as they meet certain criteria; Oklahoma, Oregon, Minnesota and Iowa have applied for waivers and New Hampshire and Maine are considering similar programs.